Cargando…

Cerebrospinal Fluid Hypocretin and Nightmares in Dementia Syndromes

BACKGROUND/AIMS: Hypocretin promotes wakefulness and modulates REM sleep. Alterations in the hypocretin system are increasingly implicated in dementia. We evaluated relationships among hypocretin, dementia biomarkers, and sleep symptoms in elderly participants, most of whom had dementia. METHODS: On...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trotti, Lynn Marie, Bliwise, Donald L., Keating, Glenda L., Rye, David B., Hu, William T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989783/ https://www.ncbi.nlm.nih.gov/pubmed/33790936 http://dx.doi.org/10.1159/000509585

Ejemplares similares

Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy
por: Lopez, Régis, et al.
Publicado: (2017)

Central Disorders of Hypersomnolence, Restless Legs Syndrome, and Surgery With General Anesthesia: Patient Perceptions
por: LaBarbera, Vincent, et al.
Publicado: (2018)

Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjögren’s syndrome
por: Bårdsen, Kjetil, et al.
Publicado: (2019)

Evidence for communication of peripheral iron status to cerebrospinal fluid: clinical implications for therapeutic strategy
por: Connor, James R., et al.
Publicado: (2020)

Cerebrospinal Fluid Hypocretin-1 (Orexin-A) Level Fluctuates with Season and Correlates with Day Length
por: Boddum, Kim, et al.
Publicado: (2016)

Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1
por: van der Hoeven, Adrienne Elisabeth, et al.
Publicado: (2022)

Hypocretin-1 measurements in cerebrospinal fluid using radioimmunoassay: within and between assay reliability and limit of quantification
por: van der Hoeven, Adrienne Elisabeth, et al.
Publicado: (2022)

Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer’s Disease
por: Schmidt, Frank M., et al.
Publicado: (2013)

From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid
por: Hirtz, Christophe, et al.
Publicado: (2016)

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness
por: Omori, Yuki, et al.
Publicado: (2018)

Decreased Cerebrospinal Fluid Orexin-A (Hypocretin-1) Concentrations in Patients after Generalized Convulsive Status Epilepticus
por: Samzadeh, Mojdeh, et al.
Publicado: (2020)

Correction: Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer’s Disease
por: Schmidt, Frank M., et al.
Publicado: (2013)

Hypocretin-1 levels in the cerebrospinal fluid of patients with Percheron artery infarction with or without midbrain involvement: A case series
por: Suzuki, Keisuke, et al.
Publicado: (2016)

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
Publicado: (2018)

Nightmare
por: Moore, William
Publicado: (1889)

Cerebrospinal fluid catecholamines in delirium and dementia
por: Henjum, Kristi, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
por: Mukaetova-Ladinska, Elizabeta B., et al.
Publicado: (2010)

Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
por: Ljubenkov, Peter A., et al.
Publicado: (2018)

Editorial: Hypocretins/Orexins
por: López, Miguel, et al.
Publicado: (2020)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

Cerebrospinal fluid analysis in individuals with diabetes-related dementia
por: Kanetaka, Hidekazu, et al.
Publicado: (2017)

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies
por: Foska, Aikaterini, et al.
Publicado: (2022)

Hypocretins, sleep, and maternal behavior
por: Rivas, Mayda, et al.
Publicado: (2023)

Dealing with Posttraumatic Nightmares
por: Alvarez Garcia, C., et al.
Publicado: (2022)

Cerebrospinal Fluid
por: Bailey, Cleta Sue, et al.
Publicado: (1997)

A neurocomputational theory of nightmares: the role of formal properties of nightmare images
por: McNamara, Patrick, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
por: Forlenza, Orestes V., et al.
Publicado: (2015)

Different Inflammatory Signatures in Alzheimer’s Disease and Frontotemporal Dementia Cerebrospinal Fluid
por: Boström, Gustaf, et al.
Publicado: (2021)

Cerebrospinal Fluid
por: Vernau, William, et al.
Publicado: (2008)

Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
por: Meeter, Lieke H H, et al.
Publicado: (2019)

PRESCRIBER'S NIGHTMARE
por: Shamasundar, C.
Publicado: (1992)

Dreams and nightmares
por: Hadfield, J. A. 1882-1967 (James Arthur)

Nightmares and hopes
por: Casimir, Hendrik Brugt Gerhard, et al.
Publicado: (1988)

Nightmare Abbey
por: Sharp, John Anthony 1915-

Nightmare and Dreaming
por: Winn, J. M.
Publicado: (1876)

The Physiology of Nightmare
por: Wooton, Edwin
Publicado: (1879)

Nightmares and the Cannabinoids
por: Mamelak, Mortimer
Publicado: (2020)

Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Self-Administration Is Mediated Predominantly by Hypocretin Receptor 1
por: Prince, Courtney D., et al.
Publicado: (2014)

Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels
por: Bloniecki, Victor, et al.
Publicado: (2014)

VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rcvdd614d9065b1plmr67f0fp4